Long-Term Survival after Kidney Transplantation This review discusses demographics,
survival, and risks in kidney transplantation since the mid-1990s. It addresses postoperative …

Late antibody‐mediated rejection (ABMR) is a cardinal cause of kidney allograft failure,
manifesting as a continuous and, in contrast with early rejection, often clinically silent …

Sensitized kidney transplant recipients experience high rates of antibody-mediated rejection
due to the presence of donor-specific antibodies and immunologic memory. Here we show …

Background Donor-specific antibodies are associated with increased risk of antibody-
mediated rejection and decreased allograft survival. Therefore, reducing the risk of these …

Introduction Antibody-mediated rejection (ABMR) is a leading cause of kidney allograft
failure. Its therapy continues to be challenge, and no treatment has been approved for the …

There is an urgent need for therapeutic interventions for desensitization and antibody-
mediated rejection (AMR) in sensitized patients with preformed or de novo donor-specific …

Background Xenotransplantation has made tremendous progress over the last decade.
Methods We discuss kidney and heart xenotransplantation, which are nearing initial clinical …

Active antibody-mediated rejection (AMR) is a potentially devastating complication and
consistently effective treatment remains elusive. We hypothesized that the reversal of acute …

Background Patients with broad HLA sensitization have poor access to donor organs, high
mortality while waiting for kidney transplant, and inferior graft survival. Although …

Antibody‐mediated rejection (ABMR) in kidney transplantation is a major cause of late graft
loss, and despite all efforts to date the “standard of care” remains plasmapheresis, IVIg, and …